American Renal Associates Announces Third Quarter 2012 Results

Comments
Print

BEVERLY, Mass.—American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended September 30. Financial and operating highlights include:

  • Revenues—Patient service operating revenues for the three and nine months ended September 30 were $108.3 million and $307.3 million, respectively, as compared to $92.7 million and $267.0 million, respectively, for the same periods in 2011.
  • Adjusted EBITDA(1)—Adjusted EBITDA for the three and nine months ended September 30 was $20.9 million and $58.5 million, respectively. This compares to Adjusted EBITDA for the three and nine months ended September 30, 2011 of $17.3 million and $48.3 million, respectively.
  • Center Activity—As of September 30, 2012, we provided services at 125 outpatient dialysis centers serving 8,312 patients. During the third quarter of 2012, we opened 7 de novo centers and acquired 1 center.
  • Volume—Total treatments for the third quarter of 2012 were 301,901 or 3,871 treatments per day, representing a per day increase of 17.2 percent over the third quarter of 2011. Non-acquired treatment growth was 8.5 percent in the third quarter.

American Renal Associates will hold a conference call to discuss its results for the third quarter ended September 30, 2012 today at 5:00 p.m. Eastern Time. The live call can be accessed by dialing either 1-877-407-8029 or 201-689-8029.



Comments
comments powered by Disqus